JF
AMGN icon

JMN Financial’s Amgen AMGN Stock Holding History

JMN Financial’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$399K Buy
1,103
+275
+33% +$94.1K 0.31% 92
2026
Q1 		$291K Buy
+828
New +$295K 0.29% 116

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

JMN Financial's AMGN Position: Q2 2026 in Review

JMN Financial increased its Amgen (AMGN) stake by 33% in Q2 2026, buying an estimated $94.1K and bringing the position to 1,103 shares worth $399K. The position accounts for 0.31% of the portfolio, ranked #92.

JMN Financial first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. 3,029 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • JMN Financial held 1,103 shares of Amgen worth $399K as of Q2 2026.
  • JMN Financial bought 275 Amgen shares in Q2 2026, an estimated $94.1K.
  • Amgen made up 0.31% of JMN Financial's portfolio in Q2 2026, its #92 holding.
  • JMN Financial first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
  • 3,029 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on JMN Financial's 13F filing for Q2 2026, filed 10 Aug 2026.